mounjaro vs glp-1 Semaglutide Ozempic vs Wegovy vs Mounjaro vs Ozempic- Key Differences

Still today, individuals with diabetes have an approximately two-fold increased risk of all-cause mortality than those without diabetes [3]

In a study published in May, researchers used a large patient dataset to compare the NAION rate within 1 year of adults with Type 2 diabetes starting GLP-1 treatment (like Ozempic) versus those starting dipeptidyl peptidase 4 inhibitors

With this in mind, an emerging consumer base will attract attention, namely retired GLP-1 users, as they can experience semaglutide withdrawal symptoms and weight gain which may require a unique set of solutions

Despite overlapping benefits, growing evidence suggests that these agents have distinct and complementary roles in clinical practice

Savchenko LG, Digtiar NI, Selikhova LG, Kaidasheva EI, Shlykova OA, Vesnina LE, et al

Copyright 2026 Target Patients LLC